Selective incorporation of polyanionic molecules into hamster prions

被引:80
作者
Geoghegan, James C.
Valdes, Pablo A.
Orem, Nicholas R.
Deleault, Nathan R.
Williamson, R. Anthony
Harris, Brent T.
Supattapone, Surachai
机构
[1] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA
[2] Dartmouth Med Sch, Dept Pathol, Hanover, NH 03755 USA
[3] Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA
[4] Scripps Res Inst, La Jolla, CA 92037 USA
关键词
D O I
10.1074/jbc.M704447200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The central pathogenic event of prion disease is the conformational conversion of a host protein, PrPC, into a pathogenic isoform, PrPSc. We previously showed that the protein misfolding cyclic amplification (PMCA) technique can be used to form infectious prion molecules de novo from purified native PrPC molecules in an autocatalytic process requiring accessory polyanions (Deleault, N. R., Harris, B. T., Rees, J. R., and Supattapone, S. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 9741-9746). Here we investigated the molecular mechanism by which polyanionic molecules facilitate infectious prion formation in vitro. In a PMCA reaction lacking PrPSc template seed, synthetic poly(A) RNA molecules induce hamster (Ha) PrPC to adopt a protease-sensitive, detergent-insoluble conformation reactive against antibodies specific for PrPSc. During PMCA, labeled nucleic acids form nuclease-resistant complexes with HaPrP molecules. Strikingly, purified HaPrP(C) molecules subjected to PMCA selectively incorporate an similar to 1 -2.5-kb subset of [P-32] poly(A) RNA molecules from a heterogeneous mixture ranging in size from similar to 0.1 to > 6 kb. Neuropathological analysis of scrapie-infected hamsters using the fluorescent dye acridine orange revealed that RNA molecules co-localize with large extracellular HaPrP aggregates. These findings suggest that polyanionic molecules such as RNA may become selectively incorporated into stable complexes with PrP molecules during the formation of native hamster prions.
引用
收藏
页码:36341 / 36353
页数:13
相关论文
共 84 条
[1]   Small, highly structured RNAs participate in the conversion of human recombinant PrpSen to PrpRes in vitro [J].
Adler, V ;
Zeller, B ;
Kryukov, V ;
Kascsak, R ;
Rubenstein, R ;
Grossman, A .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 332 (01) :47-57
[2]   ENDOGENOUS VIRAL COMPLEXES WITH LONG RNA COSEDIMENT WITH THE AGENT OF CREUTZFELDT-JAKOB-DISEASE [J].
AKOWITZ, A ;
SKLAVIADIS, T ;
MANUELIDIS, L .
NUCLEIC ACIDS RESEARCH, 1994, 22 (06) :1101-1107
[3]   PROTECTED ENDOGENOUS RETROVIRAL SEQUENCES COPURIFY WITH INFECTIVITY IN EXPERIMENTAL CREUTZFELDT-JAKOB-DISEASE [J].
AKOWITZ, A ;
MANUELIDIS, EE ;
MANUELIDIS, L .
ARCHIVES OF VIROLOGY, 1993, 130 (3-4) :301-316
[4]   Kinetic intermediate in the folding of human prion protein [J].
Apetri, AC ;
Surewicz, WK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (47) :44589-44592
[5]   Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments [J].
Apetri, Adrian C. ;
Maki, Kosuke ;
Roder, Heinrich ;
Surewicz, Witold K. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (35) :11673-11678
[6]  
Bell JE, 1997, NEUROPATH APPL NEURO, V23, P26, DOI 10.1111/j.1365-2990.1997.tb01182.x
[7]   Cellular heparan sulfate participates in the metabolism of prions [J].
Ben-Zaken, O ;
Tzaban, S ;
Tal, Y ;
Horonchik, L ;
Esko, JD ;
Vlodavsky, I ;
Taraboulos, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (41) :40041-40049
[8]   Bending and unwinding of nucleic acid by prion protein [J].
Bera, A. ;
Roche, A. -C. ;
Nandi, P. K. .
BIOCHEMISTRY, 2007, 46 (05) :1320-1328
[9]   In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrPSc [J].
Bocharova, OV ;
Breydo, L ;
Parfenov, AS ;
Salnikov, VV ;
Baskakov, IV .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 346 (02) :645-659
[10]   Cultured cell sublines highly susceptible to prion infection [J].
Bosque, PJ ;
Prusiner, SB .
JOURNAL OF VIROLOGY, 2000, 74 (09) :4377-4386